Close Menu

Books in a Library

Hepatocelluar carcinoma

Value of the Serum Galectin 3 in Patients with Hepatocelluar Carcinoma: A Meta-analysis

Serum Galectin 3 is a promising diagnostic indicator for some carcinomas. This study estimated the serum Gal-3 in patients with hepatocelluar carcinoma. And learn that the expression of serum Galectin 3 possibility tended to be a bigger biomarker for diagnosis of HCC.


Objective: To investigate the connection of galectin 3 with HCC risk.

Methods: Publications were searched using PubMed, MEDLINE, EMBASE and the Chinese databases (including CNKI and WanFang) up to October 2015.

03 Jan, 2017
PDF Attachment: 
Journal Sections: 
Journal Authors: 
e-Published: 30 Jan, 2017


Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Subscribe to RSS - Hepatocelluar carcinoma
Top of Page